Y Intercept (Hong Kong) LTD Sarepta Therapeutics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 47,382 shares of SRPT stock, worth $565,267. This represents 0.22% of its overall portfolio holdings.
Number of Shares
47,382
Previous 9,090
421.25%
Holding current value
$565,267
Previous $1.11 Million
173.57%
% of portfolio
0.22%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding SRPT
# of Institutions
492Shares Held
89.8MCall Options Held
1.39MPut Options Held
1.11M-
Black Rock Inc. New York, NY10.3MShares$123 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$108 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$108 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$48.5 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$40.1 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.04B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...